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Although the activating factor NF-cB can be present in the nucleus of many cell types, transcription and
rearrangement of the immunoglobulin kappa chain gene is restricted to cells of the B lineage. Part of this
specificity is determined by sequences within the major intron of the kappa gene that specifically silence gene
expression in non-B cells (T cells and HeLa cells). These sequences are found in a 232-bp fragment located 5'
of the NF-KB binding sequence of the enhancer. When this fragment is added back upstream of an active
NF-KB site, it specifically decreases the expression of a linked gene by more than 10-fold in activated T cells but
it has no effect on expression in B cells. The kappa silencer region acts in an orientation- and distance-
independent manner and appears to be composed of multiple negative elements. The kappa silencer may act
to restrict transcription and rearrangement of the CK locus to cells of the B lineage.
The immunoglobulin kappa chain gene is under precise
developmental control. This gene is expressed only in cells
of the B-lymphocyte lineage. The transcription of the murine
kappa locus is regulated by the binding of nuclear factors to
DNA sequences within the V,< promoters and the two
enhancer regions, one located within the J-C,K intron and
another located downstream of the CK coding region (5, 13,
15, 32, 40, 42). Several regulatory sequences within the
intron enhancer are important for enhancer function in B
cells (14, 27, 46). These include the E motifs (KE1, KE2, and
KE3), which are homologous to the protein-binding consen-
sus sequence CAGGTGGC in the immunoglobulin heavy-
chain enhancer and the kB site, GGGACTTTCC, which
binds the nuclear factor NF-KB (46). The activation of both
CK transcription and rearrangement occurs at the pre-B- to
B-cell transition and is correlated with the induction of
NF-KB (37, 39, 47, 51). In pre-B cells, NF-KB exists in an
inactive cytoplasmic form where it is complexed with an
inhibitor, IKB (3). Upon induction of pre-B cells, IKB under-
goes a phosphorylation event and NF-KB is translocated to
the nucleus, where it can bind DNA (2-4, 17, 47). The
DNA-binding form of NF-KB is present constitutively only
in mature B cells and plasma cells which express kappa
light-chain genes. Binding of NF-KB to the enhancer is
crucial to the activation ofgene transcription, since mutation
of the NF-KB binding site abolishes kappa enhancer activity
(27).
The NF-KB protein was originally identified in cells of the
B lineage. However, NF-KB and related factors can be
induced in many cell types by treatment with phorbol
12-myristate 13-acetate (PMA), interleukin-1, double-
stranded RNA, or viral infection (29, 47, 52). Treatment ofT
cells or HeLa cells with PMA induces NF-KB (2, 47). In
non-B cells, NF-KB and related proteins have pleiotropic
effects, activating a broad range of different genes (reviewed
in reference 28). For example, NF-KB is induced upon T-cell
activation, and it stimulates transcription of many genes,
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including interleukin-2 receptor alpha chain (7). Signifi-
cantly, NF-KB can also activate several viral enhancers,
including the human immunodeficiency virus enhancer, the
simian virus 40 enhancer, and the cytomegalovirus enhancer
(8, 33).
Since NF-KB can stimulate so many different genes in T
and B cells, it is clear that NF-KB by itself cannot account
for the precise tissue-specific regulation of each of these
genes. There must be additional regulatory elements which
modify the activity of NF-KB and prevent the inappropriate
activation of all these genes at once. We and others have
previously observed that the NF-KB binding sequence alone
can activate transcription in either B cells or non-B cells
treated with PMA (36, 41, 56). However, a 476-bp AluI
fragment containing the kappa intron enhancer was not
active in T cells treated with PMA (41). Here we present
evidence that sequences associated with the kappa chain
intron enhancer actively silence gene expression in non-H
cells. The role of the kappa silencer may be to restrict
activation of the kappa gene to cells of the B lineage.
MATERIALS AND METHODS
Cell lines, transfections, and enzymatic assays. Jurkat (hu-
man T cell), EL4 (mouse T cell), YAC-1 (mouse T cell), and
S194 (mouse B-lineage plasma cell) cell lines were grown in
RPMI 1640 medium with 10% fetal bovine serum. HeLa cells
were grown in Dulbecco's modified Eagle's medium (DME)
with 10% bovine calf serum. Cells were transfected by the
DEAE-dextran technique as modified by Grosschedl and
Baltimore (21) with 10 ,ug of test plasmid for 107 cells. The
transfected T or HeLa cells were grown in two flasks, and at
24 h after transfection, one half of the cells were treated with
PMA (50 ng/ml; Sigma) for 18 h. The Jurkat cells were
induced with both PMA (50 ng/ml) and 2 ,ug of phytohemag-
glutinin (PHA; ICN Immunobiologicals, Lisle, Ill.) per ml.
Cells were harvested at 42 h after transfection, and extracts
were prepared and heat treated for 7 min at 60°C as de-
scribed previously (41). Chloramphenicol acetyltransferase
(CAT) assays were carried out with 50 jig of protein (Jurkat,
EL4, YAC-1, and HeLa cells) or 20 ,ug of protein (S194 cells)
as described previously (20, 41). Each result represents the
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FIG. 1. Immunoglobulin kappa intron enhancer is not inducible in T cells. Relative levels of CAT activity from plasmids transfected into
Jurkat cells. After 24 h, one half of the cells were treated with PMA (50 ng/ml) and PHA (2 pLg/ml) for 18 h. Values for fold induction indicate
percent conversion in PMA-induced cells divided by percent conversion in uninduced cells. Each value represents the average of three or
more independent transfections, and the standard deviation was less than 20%. The thin arrow represents the start of transcription. Solid
boxes represent sequences which bind NF-KB within a 26-bp oligonucleotide or the kappa enhancer 476-bp AluI fragment. Line 1,
A71-fos-CAT plasmid (18); lines 2 and 3, described in Pierce et al. (41); lines 4 and 5, described in Lenardo et al. (27).
average of three or more independent transfections. The
standard deviation was less than 20%.
Plasmid constructions. The plasmid A71-fos-CAT was de-
scribed by Gilman et al. (18) and contains a minimal c-fos
promoter (-71 to + 109) driving the cat gene. The sequence
upstream of the c-fos promoter is from the pUC13 poly-
linker, including a unique HindIII site and SaII site. Plasmids
containing the NF-KB binding site (KB) included one or two
copies of the 26-bp oligonucleotide sequence TCGACA
GAGGGGACTTTCCGAGAGGC inserted at the unique
Sall site of A71-fos-CAT as described by Pierce et al. (41)
(for the J17 plasmid, see line 2 of Fig. 2 in reference 41; for
J18 see line 5 of Fig. 2 in reference 41). The Kappa-CAT
plasmid contains the 476-bp AluI fragment (positions 3692 to
4166, numbering according to Emorine et al. [13]) from the
kappa intron inserted at the SalI site in A71-fos-CAT as
described by Lenardo et al. (27). For constructs J44, J45,
J53, J58, J59, J61, J65, and J56 in Fig. 3, test fragments were
inserted at a unique Sall site immediately upstream of the KB
site in the plasmid J17, which contains one KB site driving
transcription of the c-fos-cat gene. The plasmids in Fig. 4
were derived by inserting test fragments at a unique Hindll
site 18 bp upstream of the two KB sites in J18.
RESULTS
Restricted activity of the kappa enhancer in T cells. The
kappa intron enhancer is known to be B-cell specific (40, 42).
Its activity is dependent on the binding of nuclear factor
NF-KB, which is induced during maturation of pre-B cells.
Because NF-KB and related factors can also be induced in T
and HeLa cells treated with PMA, we tested the activity of
the kappa enhancer in these cells. We inserted the 476-bp
AluI fragment containing the mouse kappa intron enhancer
into a test plasmid containing the mouse c-fos promoter
driving the cat gene (Fig. 1; line 1, test plasmid; lines 4 and
5, with kappa enhancer). In addition, we tested plasmids
containing either one or two copies of the binding sequence
for NF-KB (KB) inserted as a 26-bp oligonucleotide immedi-
ately upstream of the promoter (Fig. 1, lines 2 and 3). These
plasmids were transfected into T cells (Jurkat), and after 24
h, half of the cells were treated with PMA and PHA to
induce NF-KB. We determined CAT enzyme activity after 42
h as a measure of gene transcription.
Consistent with previous observations, the plasmids con-
taining one KB site gave 6-fold induction while those con-
taining two KB sites gave 180-fold induction of CAT activity
after treatment with PMA and PHA (41). The kappa en-
hancer fragment, by contrast, showed no induction under
these conditions even though its activity in B cells is
equivalent to that of two KB sites (41). A similar lack of
activity was obtained with other T-cell lines (EL4 and
YAC-1) and with Jurkat cells induced with PMA alone.
Thus, the kappa enhancer appears to have an activity that
restricts its action to B cells.
To determine whether particular sequences within the
enhancer region act as negative elements in T cells, we
inserted either the kappa enhancer fragment (476 bp) or a
nonspecific spacer fragment from pUC19 (473 bp) into the
plasmid containing two KB sites. These fragments of DNA
were placed between the KB sites and the promoter (Fig. 2).
The pUC19 spacer fragment had only a small effect on the
ability of KB sites to drive transcription of the cat gene, but
the same size fragment from the kappa enhancer reduced
activity to 9o of the control. This result implies that the
kappa enhancer region contains sequences which domi-
nantly inhibit transcription in activated T cells. We will call
these sequences silencers for the reasons given below.
Silencing sequences. To search for silencer elements within
the kappa enhancer region, the whole enhancer or fragments
from the 476-bp enhancer region were added back at a
unique Sall site upstream of the KB site in the KB-fos-CAT
test plasmids (Fig. 3A and B). In these "add back" experi-
ments, the position of the KB site, fos promoter, and cat gene
remained constant. These plasmids were then transfected
into Jurkat cells, and one half of the cells were treated with
PMA and PHA to induce NF-KB. Under these conditions, a
single KB site gives an average of sixfold induction of CAT
activity (Fig. 1, line 2). When the entire 476-bp kappa
fragment was present upstream in either orientation, the
induced CAT activity was decreased to about 30% of that
seen with the KB site alone (Fig. 3B, J45 and J44 versus J17).
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FIG. 2. Sequences within the kappa enhancer 476-bp fragment decrease gene expression in T cells. Plasmids were transfected into EL4
T cells, and after 24 h cells were treated with PMA for 18 h as described in Materials and Methods. Relative CAT values were obtained by
comparison with activity from the plasmid shown in line 1. The solid boxes indicate NF-KB binding sequences within a 26-bp oligonucleotide
or within the kappa enhancer.
In S194 myeloma cells, plasmids containing the kappa
476-bp fragment gave five times more activity than the
KB-only constructs (Fig. 3B). Thus, in the presence of two
KB sites, the whole enhancer has the predicted positive
effect in B cells but a net negative effect in T cells. This result
highlights the power of the negative elements in T cells.
We then attempted to separate the positive and negative
elements by dividing the enhancer region in half so that the
KB site and the three E motifs were in the 3' half and the
remaining 232 bp were in the 5' half. This was done by
inserting a unique BglII site at position 3924, just upstream
of the NF-KB site (Fig. 3A). Some positive elements may still
be present in the 5' half (232 bp) of the enhancer (34, 43). The
BgIII site had no effect on kappa enhancer function in B or T
cells (data not shown). In either orientation, the 232-bp
fragment from the 5' half (positions 3692 to 3924) decreased
transcription in T cells about 10-fold relative to the KB-fos-
cat plasmid alone (Fig. 3B, J53 and J58 versus J17). When
the same plasmids were tested in B cells, the 232-bp frag-
ment did not have any effect, suggesting that it contains
mainly negative regulators whose activity is specific to
non-B cells.
We also tested the 3' half of the kappa enhancer region
(3924 to 4166) for its effect on transcription. This fragment
contains the KB, El, E2, and E3 sites. It increased transcrip-
tion about twofold in T cells but had a much greater effect in
B cells (Fig. 3B, J59). This difference may reflect the fact
that E motifs preferentially enhance transcription in B cells,
but it is also possible that negative elements exist within the
3' half of the kappa enhancer. Further study of this issue is
required.
To determine whether the effect of the 5' silencer region
was specific to T cells or could be observed in nonlymphoid
cells as well, we tested our constructs in HeLa cells treated
with PMA to induce NF-KB. Plasmids containing the 232-bp
fragment showed a silencing effect, giving three- to fivefold
less activity than those containing KB alone (Fig. 3B). These
results suggest that sequences in the kappa enhancer region
can decrease gene expression in nonlymphoid cells. We also
tested whether the intact kappa enhancer could be induced
in HeLa cells upon treatment with PMA. The Kappa-CAT
plasmid (Fig. 1, line 5) was tested in HeLa cells, and the
476-bp kappa enhancer fragment gave little or no enhancer
activity in PMA-induced HeLa cells, while constructs con-
taining just one NF-KB site gave 8- to 14-fold induction of
gene expression (data not shown). The silencing in HeLa
cells was not as great as that in T-cell lines, perhaps due to
real differences in silencer function in these cell types but
alternatively because of differences in transfection effi-
ciency. In HeLa cells, the number of plasmid molecules per
cell may be greater and the putative proteins binding to the
negative elements could be limiting.
The kappa silencer was also tested for the ability to act on
heterologous enhancers to determine whether this silencer
was specific for KB-containing enhancers. We found no
evidence for silencing of the T cell receptor a, Rous sarcoma
virus, or Moloney murine leukemia virus enhancers (data
not shown), suggesting that the silencing may be specific for
enhancers containing KB sites.
Location of negative elements. To dissect the negative
elements in the kappa enhancer in more detail, we con-
structed a panel of BAL-31 deletions within the 232-bp
fragment 5' half and tested these smaller subfragments for
their ability to silence gene activation. When the entire
232-bp fragment was tested in two different T-cell lines
(Jurkat and YAC-1), this region gave about 10-fold silencing
of gene activity (Fig. 3C, J58). A 174-bp fragment (positions
3750 to 3924) gave full silencing activity, but a 58-bp frag-
ment (3866 to 3924) showed less than fivefold silencing (Fig.
3C, J61 and J65). Thus, deletion of the region from 3750 to
3866 resulted in the loss of some but not all silencing activity.
Deletion of 3866 to 3888 further reduced the level of silencing
(J56). Similar results were obtained in both Jurkat and
YAC-1 T-cell lines. This suggests that at least two regions
within the 232-bp fragment are important for negative regu-
lation.
Silencer elements, originally defined in Saccharomyces
cerevisiae, have the property of acting at a distance to
negatively regulate transcription (9). To test whether the
negative eiements in the 232-bp region could act at a dis-
tance, we inserted this fragment either 18 or 250 bp upstream
of the promoter in a test plasmid containing two KB sites
(Fig. 4; J18, test plasmid, J87 [18 bp upstream], and JllO [250
bp upstream]). In either position, the 232-bp fragment gave
about 10-fold silencing in T cells while no effect was seen in
B cells. Thus, this region may be defined as a silencer
because its function is distance and orientation independent.
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FIG. 3. Location of negative regulatory elements. (A) Kappa intron enhancer and subfragments. Numbering of the 476-bp AluI fragment
from the J-CK intron is according to Emorine et al. (13). Locations of relevant restriction sites within the 5' half are shown. A unique BglII
site (circled) was introduced at position 3924 by site-directed mutagenesis. Subfragments to be tested for their effects on transcription are
shown below, with the names of the test plasmids used in panels B and C. (B) Effect of kappa enhancer or subfragments on transcription was
measured by inserting fragments upstream of the NF-KB site at a unique Sall site in test plasmid J17 (top line). Plasmids were transfected into
the cell lines indicated, and T cells (Jurkat) and HeLa cells were treated to induce NF-KB. The relative levels of CAT activity after induction
are given. Values were obtained by comparison with that from the plasmid J17 (top line). n.d., Not done. (C) A panel of BAL-31 deletion
fragments were made within the 232-bp AluI-BglII fragment (3692 to 3924) as shown in panel A. The 5' endpoints of the fragments are
indicated. Each fragment extended to the BglII site at 3924 (3' end). Fragments were tested for their effect on transcription by inserting each
one at the Sall site upstream of the KB site in plasmid J17. Relative CAT activity after induction of Jurkat and YAC-1 T cells was obtained
by comparison with that from J17 (top line).
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FIG. 4. Position independence of silencer function. The 232-bp AluI-BgIII fragment was tested for effects on transcription by insertion at
different positions in the test plasmid J18. Line 1, J18, no silencer. Line 2, J87, insertion at the Hindlll site 18 bp upstream of the KB sites.
Line 3, J110, insertion 243 bp from the KB sites (DNA sequence between the silencer fragment and the KB site is from pUC19 XmnI-SspI
fragment and pUC13 polylinker sequnces). Relative CAT activities in T cells (EL4) and B cells (S194) were obtained by comparison with that
from J18. The J18 plasmid containing two KB sites was used to obtain higher absolute levels of CAT activity.
DISCUSSION
We found that tissue-specific expression of the immuno-
globulin kappa intron enhancer is the result of both positive
and negative regulation. The kappa enhancer contains neg-
ative elements which act to silence gene expression in
non-B-cell types, specifically T cells and HeLa cells. The
silencer region is located within a 232-bp fragment upstream
of the KB site. This region can function in an orientation- and
distance-independent fashion. The silencer region is proba-
bly important in restricting kappa enhancer activity to B
cells and may act to prevent the inappropriate activation of
the kappa gene by NF-KB induced in other cell types. Thus,
activation of the kappa gene in developing B cells may be a
two-step process, involving both release of the kappa si-
lencer and induction of NF-KB.
The kappa silencer region is within the 5' half of the
previously described intron enhancer and appears to be
composed of multiple negative elements. The negative ele-
ments do not appear to overlap with the KB site, as has been
described for negative elements in the human beta interferon
gene (19). The composite nature of the kappa silencer is
similar to the silencer which has recently been identified
upstream of the T-cell receptor alpha chain (TCRa) gene
enhancer (54). As with the TCRa silencer, more than one
sequence element is necessary for the full silencing effect. In
addition, the immunoglobulin heavy-chain enhancer has
been reported to be associated with multiple negative ele-
ments (25, 26, 53). It is likely that silencers, like enhancers,
may be composed of multiple sequence motifs.
The mechanism of silencer function is not known. It is
possible that DNA sequences within the silencer region may
act as binding sites for nuclear factors which act as repres-
sors of transcription. We have identified one A+T-rich
sequence which binds protein (data not shown). This site
(ATTAATTTAT, positions 3825 to 3834) is located with a
region that is important for full silencing activity. Currie and
Roeder have detected protein binding to the same A+T-rich
sequence, and they suggested that OCT-2 can bind to this
site as well as to two other sites in this region of the mouse
kappa enhancer (12, 50). An octamer-binding site has also
been identified in the human kappa enhancer (35). It is
possible that an octamer-binding protein (i.e., OCT-1) could
act to negatively regulate transcription in non-B cells. Inter-
estingly, a negative regulatory function has been proposed
for another protein that binds the octamer sequence, the
OCT-3 (also known as NF-A3) protein in teratocarcinoma
cells (30). This factor binds both the octamer ATTTGCAT
and the A+T-rich sequence TTAAAATCA (38). In addition,
octamer sequences have been implicated in negative regula-
tion of the immunoglobulin heavy-chain enhancer in T cells
(57). The specific release of silencing in B cells might reflect
competition by the B-cell-specific protein OCT-2. However,
silencing was also observed in EL4 T cells, which possess
significant levels of OCT-2. Thus, any regulation involving
octamer-binding factors is likely to be complex.
Additional proteins which bind within this region of the
kappa enhancer have been observed (12, 23, 24). Currie and
Roeder have identified a nuclear factor, NF-KE*, which was
found to be more abundant in HeLa cells than in B cells (12).
Our studies show that deletion of the KE* binding region
(positions 3866 to 3888) gives about twofold less silencing
(Fig. 3C). Thus, NF-KE* may contribute to silencer func-
tion. The preferential distribution of this protein in non-B
cells is consistent with the possibility that this protein could
act as a tissue-specific repressor.
An alternative mechanism by which silencer sequences
may act to decrease gene transcription is through interaction
with the nuclear matrix. In the yeast mating type loci, the
silencer E site binds a protein, RAP-1, which appears to be
necessary for formation of DNA loops in a nuclear scaffold
assay (22, 48, 49). The sequences flanking both the heavy-
chain and kappa enhancers are A+T rich and have been
suggested to act as matrix attachment regions (MARs) and
potential binding sites for topoisomerase 11 (10, 11). In the
case of the kappa enhancer, the previously reported MARs
lie outside the 476-bp AluI fragment and thus are not present
in the silencer region. These adjacent MARs in the kappa
intron have not been tested for possible function as negative
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regulatory elements. However, the 232-bp silencer region is
highly A+T rich and includes a protein-binding sequence,
ATTAATTTAT, which has some homology to the consen-
sus sequence for topoisomerase II binding, GTNWAYATT
NATNNR (12, 16; data not shown). In the immunoglobulin
heavy-chain enhancer, A+T-rich elements are found within
the negative regulatory regions, and the silencers adjacent to
the TCRa chain enhancer also include A+T-rich regions
with homology to the topoisomerase II consensus (25, 26,
44, 53, 54). It is not yet clear whether topoisomerase II
binding is involved in silencer function. It is likely that
silencing involves additional elements specific to each si-
lencer, because topoisomerase II alone could not account for
the different patterns of tissue specificity observed for each
silencer.
The kappa silencer may play a role in regulating both
transcription and rearrangement of the CK locus. Transcrip-
tion of the unrearranged CK gene is known to be correlated
with kappa rearrangement (37, 39, 51). In fact, treatment of
pre-B cells with lipopolysaccharide activates not only
NF-KB and kappa transcription but also kappa gene rear-
rangement (45). Germ line transcription of the immunoglob-
ulin heavy-chain genes has been correlated with recombina-
tion of these genes, and it has been proposed that
transcription of the germ line locus is a prerequisite for
recombination (1, 6). Activation of NF-KB in T cells might
lead to transcription and rearrangement of the CK loCUS,
since the recombinational apparatus appears to be the same
for B and T cells. Thus, the kappa silencer may be important
in restricting both germ line CK transcription and kappa
rearrangement to B cells. A similar role for silencer elements
in regulation of gene rearrangement has been proposed for
the TCRa locus (54). Silencers associated with the TCRa
enhancer may act to prevent Jot segments from rearranging
in yb T-cell lines, thus regulating the differentiation of (43
versus -y5 T-cell lineages. The development of cells along the
B lineage may involve specific release from kappa silencer
activity. We expect that silencers will be as important as
enhancers in dictating the tissue-specific patterns of gene
expression.
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